Genetic determinants of common epilepsies: A meta-analysis of genome-wide association studies

The Lancet Neurology

Volumn 13, Issue 9, 2014, Pages 893-903

  Anney, Richard J L ^a   Avbersek, Andreja ^a   Balding, David ^a   Baum, Larry ^a   Becker, Felicitas ^a   Berkovic, Samuel F ^a   Bradfi, Jonathan P ^a   Brody, Lawrence C ^a   Buono, Russell J ^a   Catarino, Claudia B ^a   Cavalleri, Gianpiero L ^a   Cherny, Stacey S ^a   Chinthapalli, Krishna ^a   Coffey, Alison J ^a   Compston, Alastair ^a   Cossette, Patrick ^a   De Haan, Gerrit Jan ^a   De Jonghe, Peter ^a   De Kovel, Carolien G F ^a   Delanty, Norman ^a   Depondt, Chantal ^a   Dlugos, Dennis J ^a   Doherty, Colin P ^a   Elger, Christian E ^a   Ferraro, Thomas N ^a   Feucht, Martha ^a   Franke, Andre ^a   French, Jacqueline ^a   Gaus, Verena ^a   Goldstein, David B ^a   Gui, Hongsheng ^a   Guo, Youling ^a   Hakonarson, Hakon ^a   Hallmann, Kerstin ^a   Heinzen, Erin L ^a   Helbig, Ingo ^a   Hjalgrim, Helle ^a   Jackson, Margaret ^a   Jamnadas Khoda, Jennifer ^a   Janz, Dieter ^a   Johnson, Michael R ^a   Kalviainen, Reetta ^a   Kantanen, Anne Mari ^a   Kasperaviciute, Dalia ^a   Trenite, Dorothee Kasteleijn Nolst ^a   Koeleman, Bobby P C ^a   Kunz, Wolfram S ^a   Kwan, Patrick ^a   Lau, Yu Lung ^a   Lehesjoki, Anna Elina ^a   Lerche, Holger ^a   Leu, Costin ^a   Lieb, Wolfgang ^a   Lindhout, Dick ^a   Lo, Warren ^a   Lowenstein, Daniel H ^a   Malovini, Alberto ^a   Marson, Anthony G ^a   McCormack, Mark ^a   Mills, James L ^a   Moerzinger, Martina ^a   Moller, Rikke S ^a   Molloy, Anne M ^a   Muhle, Hiltrud ^a   Newton, Mark ^a   Ng, Ping Wing ^a   Nothen, Markus M ^a   Nurnberg, Peter ^a   OBrien, Terence J ^a   Oliver, Karen L ^a   Palotie, Aarno ^a   Pangilinan, Faith ^a   Pernhorst, Katharina ^a   Petrovski, Slave ^a   Privitera, Michael ^a   Radtke, Rodney ^a   Reif, Philipp S ^a   Rosenow, Felix ^a   Ruppert, Ann Kathrin ^a   Sander, Thomas ^a   Scattergood, Theresa ^a   Schachter, Steven ^a   Schankin, Christoph ^a   Scheffer, Ingrid E ^a   Schmitz, Bettina ^a   Schoch, Susanne ^a   Sham, Pak C ^a   Sisodiya, Sanjay ^a   Smith, David F ^a   Smith, Philip E ^a   Speed, Doug ^a   Sperling, Michael R ^a   Steffens, Michael ^a   Stephani, Ulrich ^a   Striano, Pasquale ^a   Stroink, Hans ^a   Surges, Rainer ^a   Tan, K Meng ^a   Thomas, G Neil ^a   Todaro, Marian ^a   Tostevin, Anna ^a   Tozzi, Rossana ^a   Trucks, Holger ^a   Visscher, Frank ^a   Spiczak, Sarah von ^a   Walley, Nicole M ^a   Weber, Yvonne G ^a   Wei, Zhi ^a   Whelan, Christopher ^a   Yang, Wanling ^a   Zara, Federico ^a   Zimprich, Fritz ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 2; EPILEPSY; ETHNIC GROUP; FOCAL EPILEPSY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENERALIZED EPILEPSY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEREDITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 84942076987     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70171-1     Document Type: Article

References (59)

1. Hesdorffer DC, Logroscino G, Benn EK, Katri N, Cascino G, Hauser WA Estimating risk for developing epilepsy: a population-based study in Rochester, Minnesota. Neurology 2011, 76:23-27.
2. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010, 51:676-685.
3. Helbig I, Scheffer IE, Mulley JC, Berkovic SF Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol 2008, 7:231-245.
4. Poduri A, Lowenstein D Epilepsy genetics-past, present, and future. Curr Opin Genet Dev 2011, 21:325-332.
5. Allen AS, et al. De novo mutations in epileptic encephalopathies. Nature 2013, 501:217-221. Epi4K Consortium, Epilepsy Phenome/Genome ProjectEpilepsy Phenome/Genome Project.
6. Carvill GL, Heavin SB, Yendle SC, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013, 45:825-830.
7. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001, 68:1327-1332.
8. Chen Y, Lu J, Pan H, et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 2003, 54:239-243.
9. Heinzen EL, Radtke RA, Urban TJ, et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet 2010, 86:707-718.
10. Helbig I, Mefford HC, Sharp AJ, et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009, 41:160-162.
11. Epi4K: gene discovery in 4,000 genomes. Epilepsia 2012, 53:1457-1467. Epi4K Consortium.
12. Dibbens LM, Heron SE, Mulley JC A polygenic heterogeneity model for common epilepsies with complex genetics. Genes Brain Behav 2007, 6:593-597.
13. Kasperaviciute D, Catarino CB, Heinzen EL, et al. Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain 2010, 133:2136-2147.
14. Kasperaviciute D, Catarino CB, Matarin M, et al. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain 2013, 136:3140-3150.
15. Guo Y, Baum LW, Sham PC, et al. Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. Hum Mol Genet 2012, 21:1184-1189.
16. Steffens M, et al. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3, and 17q21.32. Hum Mol Genet 2012, 21:5359-5372. EPICURE Consortium, EMINet ConsortiumEMINet Consortium.
17. Berkovic SF, Howell RA, Hay DA, Hopper JL Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 1998, 43:435-445.
18. Ottman R, Lee JH, Hauser WA, Risch N Are generalized and localization-related epilepsies genetically distinct?. Arch Neurol 1998, 55:339-344.
19. Peljto AL, Barker-Cummings C, Vasoli VM, et al. Familial risk of epilepsy: a population-based study. Brain 2014, 137:795-805.
20. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399. Commission on Classification and Terminology of the International League Against Epilepsy.
21. Speed D, Hoggart C, Petrovski S, et al. A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy. Hum Mol Genet 2014, 23:247-258.
22. Lippert C, Listgarten J, Liu Y, Kadie CM, Davidson RI, Heckerman D FaST linear mixed models for genome-wide association studies. Nat Methods 2011, 8:833-835.
23. Willer CJ, Li Y, Abecasis GR METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010, 26:2190-2191.
24. Dempster ER, Lerner IM Heritability of Threshold Characters. Genetics 1950, 35:212-236.
25. Banerjee PN, Filippi D, Allen Hauser W The descriptive epidemiology of epilepsy-a review. Epilepsy Res 2009, 85:31-45.
26. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
27. Lee PH, O'Dushlaine C, Thomas B, Purcell SM INRICH: interval-based enrichment analysis for genome-wide association studies. Bioinformatics 2012, 28:1797-1799.
28. Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000, 24:343-345.
29. Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel α1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001, 68:859-865.
30. Kim SY, Chung HS, Sun W, Kim H Spatiotemporal expression pattern of non-clustered protocadherin family members in the developing rat brain. Neuroscience 2007, 147:996-1021.
31. Kim SY, Mo JW, Han S, et al. The expression of non-clustered protocadherins in adult rat hippocampal formation and the connecting brain regions. Neuroscience 2010, 170:189-199.
32. Miyake K, Hirasawa T, Soutome M, et al. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome. BMC Neurosci 2011, 12:81.
33. Braithwaite SP, Stock JB, Lombroso PJ, Nairn AC Protein phosphatases and Alzheimer's disease. Prog Mol Biol Transl Sci 2012, 106:343-379.
34. Kim SY, Yasuda S, Tanaka H, Yamagata K, Kim H Non-clustered protocadherin. Cell Adh Migr 2011, 5:97-105.
35. Piper M, Dwivedy A, Leung L, Bradley RS, Holt CE NF-protocadherin and TAF1 regulate retinal axon initiation and elongation in vivo. J Neurosci 2008, 28:100-105.
36. Masuda M, Braun-Sommargren M, Crooks D, Smith DR Golgi phosphoprotein 4 (GPP130) is a sensitive and selective cellular target of manganese exposure. Synapse 2013, 67:205-215.
37. Eid T, Tu N, Lee TS, Lai JC Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem Int 2013, 63:670-681.
38. Gonzalez-Reyes RE, Gutierrez-Alvarez AM, Moreno CB Manganese and epilepsy: a systematic review of the literature. Brain Res Rev 2007, 53:332-336.
39. Lerche H, Shah M, Beck H, Noebels J, Johnston D, Vincent A Ion channels in genetic and acquired forms of epilepsy. J Physiol 2013, 591:753-764.
40. Fernandez IF, Perez-Rivas LG, Blanco S, Castillo-Dominguez AA, Lozano J, Lazo PA VRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signaling. Cell Mol Life Sci 2012, 69:3881-3893.
41. Monsalve DM, Merced T, Fernandez IF, Blanco S, Vazquez-Cedeira M, Lazo PA Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression. Cell Death Dis 2013, 4:e513.
42. Genome-wide association study implicates HLA-C*01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry 2012, 72:620-628. Irish Schizophrenia Genomics Consortium and the Wellcome Trust Case Control Consortium 2.
43. Li M, Wang Y, Zheng XB, et al. Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility. Schizophr Res 2012, 142:200-205.
44. Steinberg S, de Jong S, Andreassen OA, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet 2011, 20:4076-4081.
45. Dao KH, Rotelli MD, Brown BR, et al. The PI3K/Akt1 pathway enhances steady-state levels of FANCL. Mol Biol Cell 2013, 24:2582-2592.
46. Vandenbroucke RE, Dejonckheere E, Van Lint P, et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases. J Neurosci 2012, 32:9805-9816.
47. Yong VW Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 2005, 6:931-944.
48. Wilczynski GM, Konopacki FA, Wilczek E, et al. Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 2008, 180:1021-1035.
49. Baum L, Haerian BS, Ng HK, et al. Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. Hum Genet 2014, 133:651-659.
50. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005, 366:371-377.
51. Abou-Khalil B, Ge Q, Desai R, et al. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology 2001, 57:2265-2272.
52. Hirose S, Scheffer IE, Marini C, et al. SCN1A testing for epilepsy: application in clinical practice. Epilepsia 2013, 54:946-952.
53. Dibbens LM, Tarpey PS, Hynes K, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet 2008, 40:776-781.
54. Berg AT, Blackstone NW Of cabbages and kings: Perspectives on classification from the field of systematics. Epilepsia 2003, 44:8-12.
55. Beecham AH, Patsopoulos NA, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013, 45:1353-1360. International Multiple Sclerosis Genetics Consortium.
56. Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2Wellcome Trust Case Control Consortium 2.
57. Ripke S, O'Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013, 45:1150-1159.
58. Heinzen EL, Depondt C, Cavalleri GL, et al. Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 2012, 91:293-302.
59. Klassen T, Davis C, Goldman A, et al. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 2011, 145:1036-1048.